Synthesis,characterisation and antibacterial studies of carbon nanoparticle and carbon nanoparticle encapsulated in functionally modified β-cyclodextrin with {5-[4-(dimethylamino) benzylidene]-4-oxo-2-thioxo-1, 3-thiazolidin-3-yl} acetic acid

This paper describes the synthesis of carbon nanoparticle (CNP) from natural sources such as kitchen soot, synthesis of a chromophoric system {5-[4-(dimethylamino) benzylidene]-4-oxo-2-thioxo1, 3-thiazolidin-3-yl} acetic acid and its incorporation into β-cyclodextrin (β-CD) through the esterification of the hydroxyl group with the free carboxyl function of the chromophoric system by DCC coupling. Encapsulation of CNP into functionally modified β-CD system was achieved. Characterisation of the products was undertaken by UV–visible, FT-IR, NMR, fluorescence spectroscopic methods, SEM, TEM and X-ray diffraction methods. Their antibacterial activities were addressed. The antibacterial activity of CNP and functionally modified β-CD-CNP products were tested against various pathogenic bacterial strains such as Streptcoccus haemoliticus (+ve), Staphylococcus aureus (+ve), Klebsiella pneumonia (?ve) and E. coli (MTCC1687) (?ve) by disc diffusion method. The results showed that the CNPs and functionally modified products have good antibacterial activity against selected pathogenic bacterial strains.     

封闭空间中新型冠状病毒肺炎传播模型:以日本“钻石公主号”邮轮为例

该文以新型冠状病毒(SARS-Cov-2)在日本钻石公主号邮轮上传播为例,通过建立简单的易感者-感染者传染病模型,研究在封闭空间中新冠病毒肺炎(COVID-19)的传播机制.动力学分析和数值拟合预测了疾病传播过程和最终结果,讨论了不同隔离措施对疾病传播进程的影响,并给出防控策略建议.     

动态数据拟合的叠合模型及其应用

对复杂现象的动态序列建模，一般单一模型效果不是太好，本给出叠合模型的建模方法，着重讨论周期性趋势的叠合模型方法，并对其作了改进。章利用改进的周期性趋势叠合模型对我国非典型肺炎临床诊断病人数作出了非常满意的拟合。     

Establishing a Klebsiella pneumoniae-Based Cell-Free Protein Synthesis System

Cell-free protein synthesis (CFPS) systems are emerging as powerful platforms for in vitro protein production, which leads to the development of new CFPS systems for different applications. To expand the current CFPS toolkit, here we develop a novel CFPS system derived from a chassis microorganism Klebsiella pneumoniae, an important industrial host for heterologous protein expression and the production of many useful chemicals. First, we engineered the K. pneumoniae strain by deleting a capsule formation-associated wzy gene. This capsule-deficient strain enabled easy collection of the cell biomass for preparing cell extracts. Then, we optimized the procedure of cell extract preparation and the reaction conditions for CFPS. Finally, the optimized CFPS system was able to synthesize a reporter protein (superfolder green fluorescent protein, sfGFP) with a maximum yield of 253 ± 15.79 μg/mL. Looking forward, our K. pneumoniae-based CFPS system will not only expand the toolkit for protein synthesis, but also provide a new platform for constructing in vitro metabolic pathways for the synthesis of high-value chemicals.     

Isolation and Characterization of Galloylglucoses Effective against Multidrug-Resistant Strains of Escherichia coli and Klebsiella pneumoniae

The search for new antibiotics against multidrug-resistant (MDR), Gram-negative bacteria is crucial with respect to filling the antibiotics development pipeline, which is subject to a critical shortage of novel molecules. Screening of natural products is a promising approach for identifying antimicrobial compounds hosting a higher degree of novelty. Here, we report the isolation and characterization of four galloylglucoses active against different MDR strains of Escherichia coli and Klebsiella pneumoniae. A crude acetone extract was prepared from Paeonia officinalis Linnaeus leaves, and bioautography-guided isolation of active compounds from the extract was performed by liquid–liquid extraction, as well as open column, flash, and preparative chromatographic methods. Isolated active compounds were characterized and elucidated by a combination of spectroscopic and spectrometric techniques. In vitro antimicrobial susceptibility testing was carried out on E. coli and K. pneumoniae using 2 reference strains and 13 strains hosting a wide range of MDR phenotypes. Furthermore, in vivo antibacterial activities were assessed using Galleria mellonella larvae, and compounds 1,2,3,4,6-penta-O-galloyl-β-d-glucose, 3-O-digalloyl-1,2,4,6-tetra-O-galloyl-β-d-glucose, 6-O-digalloyl-1,2,3,4-tetra-O-galloyl-β-d-glucose, and 3,6-bis-O-digalloyl-1,2,4-tri-O-galloyl-β-d-glucose were isolated and characterized. They showed minimum inhibitory concentration (MIC) values in the range of 2–256 µg/mL across tested bacterial strains. These findings have added to the number of known galloylglucoses from P. officinalis and highlight their potential against MDR Gram-negative bacteria.     

Polypept(o)ide-based bactericides: weapons against antibiotic-resistant bacterial infections

Emerging antibiotic resistance in bacterial pathogens has necessitated the development of alternative ‘outside of the box’ antimicrobial therapeutics. Polypept(o)ide-based bactericides with chemical structures mimicking antimicrobial host defense peptides have emerged as promising candidates for treating antibiotic-resistant and recurring infections. This review summarizes the recent advances in membrane-active polypept(o)ide-based bactericides in the treatment of antibiotic-resistant bacterial infections associated with the physical disruption of bacterial cell walls/cell membranes. Among these polypept(o)ide-based bactericides, nonantibiotic treatment strategies are employed to combat lethal bacterial strains resulting from acquired antibiotic resistance and biofilm formation, featuring the capacity to evade acquired antibiotic resistance-related mechanisms and to alleviate the emergence of drug resistance. Emphasis will focus on the typical polypept(o)ides with diverse molecular conformations (e.g., linear, brush-like, and star-shaped) and various chemical structures of monomers (e.g., α-amino acid, β-amino acid, and N-substituted glycine) that are central to the performance of antimicrobial polypept(o)ides. Finally, a brief discussion of the key challenges and prospects of polypept(o)ide-based bactericides is presented.